Which of the following best accounts for the reason why Swiss pharmaceutical companies are choosing to invest in smaller US biogenetical companies?
A. To gain access to US skilled labor
B. To gain access to a brand name
C. to gain access to research in this area
D. to gain access to the US market
E. to gain access to US natural resources
Answer: C